Aripiprazole

Brand Names: Abilify

Drug Class: Atypical antipsychotic (second-generation antipsychotic)

Overview

Aripiprazole is an atypical antipsychotic medication used to treat schizophrenia, bipolar disorder, major depressive disorder (as adjunctive therapy), irritability associated with autism, and Tourette's disorder. It functions as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors while antagonizing serotonin 5-HT2A receptors, providing a unique mechanism among antipsychotics.

Mechanism of Action

Aripiprazole acts as a partial agonist at dopamine D2 and serotonin 5-HT1A receptors, and as an antagonist at serotonin 5-HT2A receptors. This unique pharmacological profile modulates dopaminergic and serotonergic neurotransmission, stabilizing activity in mesolimbic and mesocortical pathways while minimizing extrapyramidal side effects.

Indications

  • Treatment of schizophrenia
  • Acute treatment of manic and mixed episodes associated with bipolar I disorder
  • Adjunctive treatment of major depressive disorder
  • Irritability associated with autistic disorder
  • Treatment of Tourette's disorder

Common Doses

  • 2 mg
  • 5 mg
  • 10 mg
  • 15 mg
  • 20 mg
  • 30 mg

Dosage

Dosing varies by indication: schizophrenia (10-30 mg/day), bipolar mania (15-30 mg/day), adjunctive MDD (2-15 mg/day), autism irritability (2-15 mg/day), Tourette's (2-20 mg/day). Titration is recommended based on clinical response and tolerability.

Black Box Warning

Increased mortality in elderly patients with dementia-related psychosis (boxed warning)

Contraindications

  • History of hypersensitivity reaction to aripiprazole (ranging from pruritus/urticaria to anaphylaxis)

Side Effects

  • Common: nausea, vomiting, constipation, headache, dizziness, akathisia, anxiety, insomnia
  • Serious: neuroleptic malignant syndrome, tardive dyskinesia, metabolic syndrome, hyperglycemia, weight gain, orthostatic hypotension, seizures, compulsive behaviors, leukopenia

Interactions

  • Strong CYP3A4 inhibitors (ketoconazole) increase aripiprazole levels
  • Strong CYP2D6 inhibitors (quinidine, fluoxetine, paroxetine) increase aripiprazole levels
  • CYP3A4 inducers (carbamazepine) decrease aripiprazole levels
  • Alcohol may enhance CNS depression
  • Antihypertensives may have additive hypotensive effects

Counseling Points

  • Take consistently with or without food
  • Avoid alcohol and CNS depressants
  • Rise slowly to prevent dizziness
  • Report unusual urges (gambling, shopping, eating)
  • Monitor for signs of high blood sugar (thirst, urination, hunger)
  • Do not stop abruptly without medical supervision
  • Use caution when driving or operating machinery
  • Report fever, muscle stiffness, or confusion immediately